Patient no | Age (years) | Gender | Inheritance patterns | Laterality | Betamethasone administration periods (months) | First-line treatment |
1 | 51 | M | Sporadic | OS | 22 | Dorzolamide |
2 | 51 | F | Sporadic | OD | 28 | Brinzolamide |
3 | 50 | M | Sporadic | OS | 7 | Dorzolamide |
4 | 43 | M | Sporadic | OD | 58 | Brinzolamide |
OS | 58 | Brinzolamide | ||||
5 | 51 | M | Sporadic | OD | 6 | Brinzolamide, Bromfenac |
OS | 6 | Brinzolamide, Bromfenac | ||||
6 | 35 | F | Sporadic | OD | 3 | Brinzolamide |
OS | 3 | Brinzolamide | ||||
7 | 19 | F | Autosomal dominant | OD | 20 | Brinzolamide |
OS | 20 | Brinzolamide | ||||
8 | 29 | F | Sporadic | OD | 16 | Brinzolamide |
OS | 16 | Brinzolamide | ||||
9 | 49 | M | Sporadic | OS | 4 | Brinzolamide |
10 | 16 | F | Autosomal dominant | OD | 18 | Brinzolamide |
OS | 18 | Brinzolamide |
F, female; M, male; OD, right eye; OS, left eye.